+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
543499 ACHYUT

Achyut Healthcare Share Price

 

 

Achyut Healthcare live price: ₹7.91. It opened at ₹8 vs previous close ₹8; intraday high/low: ₹8/₹8. The 50 & 200 DMA stand at ₹6.97/₹5.75.

Achyut Healthcare Performance

  • Today's Low
  • ₹8
  • Today's High
  • ₹8
  • 52 Week Low
  • ₹4
  • 52 Week High
  • ₹10
  • Open Price₹8
  • Previous Close₹8
  • Volume52,256
  • 50 DMA₹6.97
  • 100 DMA₹6.34
  • 200 DMA₹5.75

Achyut Healthcare Chart

Investment Returns

  • Over 1 Month + 21.69%
  • Over 3 Month + 45.94%
  • Over 6 Month + 37.57%
  • Over 1 Year + 116.71%

Smart Investing Starts Here Start SIP with Achyut Healthcare for Steady Growth!

Invest Now

Achyut Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 649.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 191
  • P/B Ratio
  • 5.4
  • Average True Range
  • 0.68
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.56
  • RSI
  • 56.77
  • MFI
  • 42.63

Achyut Healthcare Financials

Achyut Healthcare Technicals

EMA & SMA

Current Price
₹7.91
-0.06 (-0.75%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹7.80
  • 50 Day
  • ₹7.00
  • 100 Day
  • ₹6.30
  • 200 Day
  • ₹5.80

Resistance and Support

8.11 Pivot Speed
  • R3 9.15
  • R2 8.85
  • R1 8.41
  • S1 7.67
  • S2 7.37
  • S3 6.93

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Achyut Healthcare has an operating revenue of Rs. 11.59 Cr. on a trailing 12-month basis. An annual revenue growth of 202% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 21% and 38% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 17% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 46 which is a POOR score indicating inconsistency in earnings, a RS Rating of 93 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 48 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Achyut Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-27 Audited Results
2026-01-21 Quarterly Results & Preferential issue (Revised) issue in the ratio of 1:2 of Rs. 10/-.
2025-10-16 Half Yearly Results
2025-09-02 A.G.M.
2025-05-29 Audited Results
Date Purpose Remarks
2024-12-10 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.
Date Purpose Remarks
2024-12-10 Bonus Re.0.00 issue in the ratio of 4:10 of Re. 1/-.
2023-04-25 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 10/-.

Achyut Healthcare Shareholding Pattern

47.4%
5.13%
42.83%
4.64%

Achyut Healthcare FAQs

Achyut Healthcare share price is ₹7 As on 13 July, 2026 | 15:31

The Market Cap of Achyut Healthcare is ₹190.9 Cr As on 13 July, 2026 | 15:31

The P/E ratio of Achyut Healthcare is 649.4 As on 13 July, 2026 | 15:31

The PB ratio of Achyut Healthcare is 5.4 As on 13 July, 2026 | 15:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23